Natrixam (Indapamide, Amlodipine Besilate)

Indapamide and Amlodipine Besilate, the active ingredients in Natrixam, are a thiazide‑like diuretic and a calcium‑channel blocker presented as an oral tablet for systemic use. The combination lowers blood pressure by reducing plasma volume and causing arterial vasodilation, and it is prescribed for adult patients with hypertension.

GNH USA supplies Natrixam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Natrixam, a fixed‑dose combination of a thiazide‑like diuretic and a dihydropyridine calcium‑channel blocker, is indicated for the treatment of elevated arterial blood pressure in adult patients.

Hypertension: provides additive blood‑pressure reduction by decreasing plasma volume and inducing arterial vasodilation, helping achieve target blood‑pressure goals. Essential hypertension: lowers both systolic and diastolic pressure in patients with primary hypertension. Isolated systolic hypertension: improves systolic pressure control in older adults.

Common Side Effects: - Dizziness or light‑headedness - Headache - Peripheral edema, especially of the ankles - Flushing or warmth sensation - Fatigue - Nausea

Serious or Rare Side Effects: - Severe hypotension requiring medical attention - Electrolyte disturbances such as hypokalemia or hyponatremia - Acute renal impairment or worsening of chronic kidney disease - Angioedema or severe allergic reactions - Hepatic dysfunction with elevated transaminases - Cardiac arrhythmias, including tachycardia or bradycardia

Before initiating therapy, clinicians should assess baseline blood pressure, renal function, and electrolyte status.

- Monitor blood pressure regularly: adjust therapy if target levels are not achieved. - Check serum electrolytes: watch for potassium and sodium abnormalities. - Evaluate renal function: avoid in severe renal impairment without dose adjustment. - Use caution in elderly patients: increased sensitivity to hypotensive effects. - Avoid in patients with known severe hepatic disease. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Major Interactions (Avoid): - Other potent antihypertensives: risk of excessive hypotension. - NSAIDs: may blunt diuretic effect and impair renal function. - Potassium‑sparing diuretics: increased risk of hyperkalemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and electrolytes. - Beta‑blockers: may mask reflex tachycardia. - CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): may raise amlodipine plasma concentrations.